Pathological effects of dehydroheliotridine, a metabolite of heliotridine-based pyrrolizidine alkaloids, in the young rat.
D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D001284:Atrophy / Q000139:chemically induced; D001853:Bone Marrow / Q000473:pathology; D056486:Chemical and Drug Induced Liver Injury; D004121:Dimethyl Sulfoxide; D005260:Female; D006128:Growth / Q000187:drug effects; D006197:Hair / Q000473:pathology; D006571:Heterocyclic Compounds / Q000633:toxicity*; D007180:Incisor / Q000473:pathology; D007413:Intestinal Mucosa / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D008938:Mitosis / Q000187:drug effects; D009336:Necrosis; D011763:Pyrrolizidine Alkaloids / Q000633:toxicity*; D051381:Rats; D012469:Salivary Glands / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced; D013154:Spleen / Q000473:pathology; D013737:Testis / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology
D006571:Heterocyclic Compounds; D011763:Pyrrolizidine Alkaloids; D004121:Dimethyl Sulfoxide